Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

Michele Maio; Karl D. Lewis; Lev Demidov; Mario Mandalà; Igor Bondarenko; Paolo A. Ascierto; Christopher Herbert; Andrzej Maćkiewicz; Piotr Rutkowski; Alexander Guminski; Grant R. Goodman; Brian Simmons; Chenglin Ye; Yibing Yan; Dirk Schadendorf; Gabriela Cinat; Luis Fein; Michael P. Brown; Alexander Guminski; Andrew Haydon; Adnan Khattak; Catriona M. McNeil; Phillip Parente; Jeremy Power; Rachel Roberts‐Thomson; Shahneen Sandhu; Craig Underhill; Suresh Varma; Thomas G. Berger; Ahmad Awada; Nathalie Blockx; Véronique Buyse; Jeroen Mebis; Fábio Franke; Sérgio Jobim Azevedo; Nicolas Lazaretti; Rahima Jamal; Catalin Mihalcioiu; Teresa M. Petrella; Kerry J. Savage; Xinni Song; Ralph Wong; Nina Dabelić; Stjepko Pleština; Željko Vojnović; Petr Arenberger; Ivo Kocák; Ivana Krajsová; Eugen Kubala; Bohuslav Melichar; Yvetta Vantuchová; Kadri Putnik; Brigitte Dréno; Caroline Dutriaux; Jean‐Jacques Grob; P. Joly; J.‐P. Lacour; Nicolás Meyer; Laurent Mortier; L. Thomas; Michael Fluck; Thilo Gambichler; Jessica C. Hassel; Axel Hauschild; Dirk Schadendorf; Paul Donnellan; John McCaffrey; Derek G. Power; Samuel Ariad; Gil Bar‐Sela; Daniel Hendler; Ilan G. Ron; Jacob Schachter; Paolo A. Ascierto; Alfredo Berruti; Luca Bianchi; Vanna Chiarion‐Sileni; Francesco Cognetti; Riccardo Danielli; Anna Maria Di Giacomo; Luca Gianni; Aron Goldhirsch; Michele Guida; Michele Maio; Mario Mandalà; Paolo Marchetti; Paola Queirolo; Armando Santoro; Ellen Kapiteijn; Andrzej Maćkiewicz; Piotr Rutkowski; P. Ferreira; Lev Demidov; Georgy Gafton; Yulia Makarova; Zoran Andrić; Nada Babović; Darjana Jovanovic; Lidija Kandolf Sekulović; Graham Cohen

doi:10.1016/s1470-2045(18)30106-2

Related publications

Article2024

Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Hans Gelderblom, Vivek A. Bhadri, Silvia Stacchiotti, Sebastian Bauer, Andrew J. Wagner, Michiel A. J. van de Sande, Nicholas M. Bernthal, Antonio López–Pousa, Albiruni Abdul Razak, Antoîne Italiano, Mahbubl Ahmed, Axel Le Cesne, Gabriel Tinoco, Kjetil Boye, Javier Martín‐Broto, Emanuela Palmerini, Salvatore Tafuto, Sarah Pratap, Benjamin Powers, Peter Reichardt, Antonio Casado, Piotr Rutkowski, Christopher Tait, Fiona Zarins, B. Harrow, Maitreyi G. Sharma, Rodrigo Ruiz‐Soto, Matthew L. Sherman, Jean Yves Blay, William D. Tap, Herbert H. Loong, Antonella Brunello, Andreas H. Krieg, Mark Algulnik, Richard F. Riedel, Scott H. Okuno, Elizabeth T. Loggers, Thierry Alcindor, Virginia Ferraresi, César Serrano, R. Lor Randall, Breelyn A. Wilky, Vinod Ravi

Article2021

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Alexander Eggermont, Christian U. Blank, Mario Mandalà, Georgina V Long, Victoria Atkinson, Stéphane Dalle, Andrew Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S. Carlino, Shahneen Sandhu, James Larkin, Susana Puig, Paolo A. Ascierto, Piotr Rutkowski, Dirk Schadendorf, Rutger H.T. Koornstra, Leonel F. Hernandez‐Aya, Anna Maria Di Giacomo, Alfons J.M. van den Eertwegh,

Article2019

Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial

Mark T. Drayson, Stella Bowcock, Tim Planche, Gulnaz Iqbal, Guy Pratt, Kwee Yong, Jill Wood, Kerry Raynes, Helen Higgins, Bryony Dawkins, David Meads, Claire Hulme, Irene M. Monahan, Kamaraj Karunanithi, Helen Dignum, Edward Belsham, Jeff Neilson, Beth Harrison, Anand Lokare, Gavin Campbell, Michael R Hamblin, Peter M. Hawkey, ,

Article2021

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial

Andrew Bottomley, Corneel Coens, Justyna Mierzynska, Christian U. Blank, Mario Mandalà, Georgina V. Long, Victoria Atkinson, Stéphane Dalle, Andrew Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S. Carlino, Shahneen Sandhu, Susana Puig, Paolo A. Ascierto, James Larkin, Paul Lorigan, Piotr Rutkowski, Dirk Schadendorf, Rutger H.T. Koornstra,

Article2015

Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial

Jordi Bruix, Tadatoshi Takayama, Vincenzo Mazzaferro, Gar-Yang Chau, Jiamei Yang, Masatoshi Kudo, Jianqiang Cai, Ronnie T.P. Poon, Kwang–Hyub Han, Won Young Tak, Han Chu Lee, Tianqiang Song, Sasan Roayaie, Luigi Bolondi, Kwan Sik Lee, Masatoshi Makuuchi, Fabrício Henrique Pereira De Souza, Marie-Aude Le Berre, Gerold Meinhardt, Josep M. Llovet

The Lancet Oncology